Pontel and colleagues demonstrated that in T and B cell acute lymphoblastic leukemia, the FSP1 promoter is hypermethylated, resulting in the silencing of FSP1 expression. This evidence concerns the gene AIFM2 and acute lymphoblastic leukemia.